Erin O'Brien

The investigators suggested that future research explore the connection between ADHD risk in children and depression in pregnant parents.

This latest submission completes the FDA filing that was initiated in May.

The drug is in development for the treatment of acute depressive disorders and depression with suicidality.

Policies include opposition to government involvement in medical practice and support of access to abortion care.

Results show comparisons between intranasal and intracerebroventricular distribution of an oxytocin derivative.

Experts share the benefits of motivational interviewing when working with this patient population—and how clinicians can incorporate it into their practice.

An expert discusses key differences and some ways to avoid missing the appropriate diagnosis in these patient populations.

Connections between autism risk, sleep disturbances, insomnia risk genes and circadian pathways were analyzed.

The American Academy of Psychiatry and the Law scholarship aims to foster a welcoming and supportive environment for forensic psychiatrists of color.

The underlying neural mechanisms identified may help clinicians better understand ketamine response in human patients.

Risk of suicide attempt is higher among adults, women.

Cohort includes professionals from multiple fields, including psychiatry and medicine.

Inaugural recipients will use funds to support infrastructure, student mental health, and programs for children with behavioral challenges.

Survey results addressed connections between migraine and mental health, stigma, and treatment preferences.

Study shows promising results for early detection and prevention efforts.

Did you miss the American Psychiatric Association 2022 Annual Meeting? We've got you covered.

Treatments alter the neural processes underlying SAD symptoms.

Interim study results show 77% treatment response rate among participants.

How can we help this unique patient population thrive? Experts weigh in at the 2022 APA Annual Meeting.

Experts discuss the role of motivation and willpower in ADHD at the 2022 APA Annual Meeting.

An expert discusses the effects of long COVID on the brain at the 2022 APA Annual Meeting.

Experts discuss appropriate interventions for patients who are victims of undue influence at the 2022 APA Annual Meeting.

Experts discuss psychiatry’s role in the advancement of AI technologies at the 2022 APA Annual Meeting.

The 2022 APA Annual Meeting highlights the latest guidelines for these treatments, plus recommendations for updates and improvements.

Experts address cognitive dysfunction found in patients with long COVID at the 2022 APA Annual Meeting.

How can we more effectively help patients with PTSD? Charles B. Nemeroff discusses the diagnosis, epidemiology, and pathophysiology of PTSD, along with current and emerging treatments, at the 2022 APA Annual Meeting.

Do classification systems make a difference? A presentation at the 2022 APA Annual Meeting noted 4 key diagnoses that differ significantly in the classification systems.

This year’s winner is a pioneer for the human rights of individuals with mental illness in West Africa.

Investigators observed higher levels of depression in children and adolescents with ADHD during MPH treatment.

Recommendations are often vague, contradictory, according to investigators.